[1] International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risks to humans: man-made mineral fibres and radon[M]. Lyon: IARC, 1988. [2] Han Bingfeng, Zheng Rongshou, Zeng Hongmei, et al. Cancer incidence and mortality in China, 2022[J]. Journal of the National Cancer Center, 2024, 4(1):47-53. [3] IAEA. Methods for estimating the probability of cancer from occupational radiation exposure: IAEA-TECDOC-870[R]. Vienna, IAEA, 1996. [4] GBZ 97—2017 职业性放射性肿瘤判断规范[S]. GBZ 97—2017 Judgment standard for occupational radiogenic neoplasms[S]. [5] Darby S C, Whitley E, Howe G R, et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies[J]. Journal of the National Cancer Institute, 1995, 87(5): 378-384. [6] 孙世荃. 中国核工业辐射流行病学研究[M]. 北京: 原子能出版社, 1994. Sun Shiquan. China national nuclear industry radiation epidemiology research[M]. Beijing: Atomic Energy Press, 1994. [7] 孙世荃. 美国NIH提出的中国矿工肺癌危险系数不宜在中国使用[J]. 中国辐射卫生, 1999, 8(3): 170-171. Sun Shiquan. The lung cancer risk coefficient for Chinese miners proposed by the U.S. NIH should not be applied in China[J]. Chinese Journal of Radiological Health, 1999, 8(3): 170-171. [8] 孙世荃, 乔友林, 姚树祥, 等. 云锡矿工肺癌的氡病因学研究[J]. 辐射防护, 2001, 21(5): 278-290. Sun Shiquan, Qiao Youlin, Yao Shuxiang, et al. Radon exposure in the etiology of lung cancer of miners in Yunnan tin corporation[J]. Radiation Protection, 2001, 21(5): 278-290. [9] 张艳娜, 武晓燕, 薛向明, 等. 使用不同修正时某铀矿矿工氡致肺癌超额相对危险系数估算[J]. 中国职业医学, 2023, 50(1): 99-103. Zhang Yanna, Wu Xiaoyan, Xue Xiangming, et al. Preliminary estimation of lung cancer risk of radon exposure in a uranium mine using different corrections[J]. China Occupational Medicine, 2023, 50(1): 99-103. [10] Land C, Gilbert E, Smith J M. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables[R]. Washington: U.S. Department of Health and Human Services, 2003. [11] 中华人民共和国国家卫生健康委员会. 关于印发《职业病分类和目录》的通知[EB/OL]. (2024-12-11)[2026-01-07]. https://www.gov.cn/zhengce/zhengceku/202412/content_6992843.htm. National Health Commission of the People’s Republic of China. Notice on the issuance of the “classification and list of occupational diseases”[EB/OL]. (2024-12-11)[2026-01-07]. https://www.gov.cn/zhengce/zhengceku/202412/content_6992843.htm. [12] 滕熠, 张晓丹, 夏昌发, 等. 中国与全球癌症发病、死亡和患病对比及其预测分析: GLOBOCAN 2022数据解读[J]. 中华肿瘤防治杂志, 2024, 31(23): 1413-1420. Teng Yi, Zhang Xiaodan, Xia Changfa, et al. Comparison and predictive analysis of cancer incidence, mortality, prevalence in China and Globally: an interpretation of GLOBOCAN 2022[J]. Chinese Journal of Cancer Prevention and Treatment, 2024, 31(23): 1413-1420. [13] GB 16386—1996 放射性肿瘤判断标准及处理原则[S]. [14] GBZ 97—2002 放射性肿瘤诊断标准[S]. [15] GBZ 97—2009 放射性肿瘤病因判断标准[S]. [16] Zhu Qian, Yao Yifei, Chen Ru, et al. Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022[J]. Science China. Life Sciences, 2025, 68(5): 1478-1486. [17] 宁静, 袁勇, 谢向东, 等. 辐射致癌病因概率计算方法研究进展[J]. 军事医学科学院院刊, 2009, 33(6): 570-573. Ning Jing, Yuan Yong, Xie Xiangdong, et al. Research advances in probability of causation calculation of radiogenic neoplasms[J]. Bulletin of the Academy of Military Medical Sciences, 2009, 33(6): 570-573. [18] 孙世荃. 辐射致癌病因概率的计算方法及其应用的进展[J]. 中华放射医学与防护杂志, 1999, 19(2): 135-137. Sun Shiquan. Advances in the calculation methods and applications of radiation carcinogenesis risk probability[J]. Chinese Journal of Radiological Medicine and Protection, 1999, 19(2): 135-137. [19] 孙志娟, 王继先. 《职业性放射性肿瘤判断规范》解读[J]. 中华放射医学与防护杂志, 2017, 37(9): 696-699. Sun Zhijuan, Wang Jixian. Explanation of judgment standard for occupational radiogenic neoplasms[J]. Chinese Journal of Radiological Medicine and Protection, 2017, 37(9): 696-699. [20] Qiu Haibo, Cao Sumei, Xu Ruihua. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J]. Cancer communications, 2021, 41(10): 1037-1048. [21] Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a Cancer Journal for Clinicians, 2021, 71(3): 209-249. |